CUV 2.87% $15.39 clinuvel pharmaceuticals limited

Food for Thought, page-31

  1. 26,715 Posts.
    lightbulb Created with Sketch. 4553
    Yes, the cancelling of shares is the very definition of a share buy back. The remaining shares consequently aportion a greater equity stake and are therefore more valuable. It’s the opposite of a cash raise when new shares are issued and existing shares become devalued because each share is for a smaller bit of the company. In a way, you weren’t completely wrong saying theoretically they could eventually resell the BB shares equating to no overall cost… in other words, a cash raise exactly equivalent to the cash cost of the buy back… (or they can issue any amount of new shares in a CR subject to ASX rules) but that’s the last thing they should be doing if the company progresses and it would look pretty stewpid. But I have seen companies raise some time after a buy back and you just have to roll your eyes and wonder!
    Last edited by CEOChair: 30/03/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.39
Change
0.430(2.87%)
Mkt cap ! $771.0M
Open High Low Value Volume
$14.96 $15.39 $14.83 $2.149M 141.3K

Buyers (Bids)

No. Vol. Price($)
1 590 $15.29
 

Sellers (Offers)

Price($) Vol. No.
$15.41 1079 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.